GV 2019 Gp, LLC, 10% Owner at Prime Medicine, Inc. (PRME), sold 370,484 shares at $12.72 ($4.7M) on 2023-05-12, disclosed to the SEC on 2023-05-16.
Scheduled sale ($4.7M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.72 | 27,290 | $347K | 7.4% |
| 2 | $12.72 | 27,290 | $347K | 7.4% |
| 3 | $12.74 | 157,952 | $2.0M | 42.6% |
| 4 | $12.74 | 157,952 | $2.0M | 42.6% |
| Total | $12.74 avg | 370,484 | $4.7M | 100% |
| Filing → |
| LIFE | SELL | 2026-07-23 | $1.4M | — | Filing → |
| LIFE | SELL | 2026-07-21 | $730K | — | Filing → |
| LIFE | SELL | 2026-07-17 | $1.8M | — | Filing → |